Results 171 to 180 of about 10,488 (304)

Significance of Serum Tumor Markers in Esophageal and Gastric Cancers: A Systematic Literature Review

Annals of Gastroenterological Surgery, Volume 10, Issue 1, Page 54-66, January 2026.
The utility of serum tumor markers in esophageal squamous cell carcinoma and gastric cancer were evaluated by systematic review and meta‐analysis. In addition, the position of each marker, strategies for improving their accuracy in the future, and new markers are also described.
Yasunori Matsumoto, Takeshi Toyozumi, Hideaki Shimada   +2 more
wiley   +1 more source

Integration of circulating biomarkers and clinical factors: construction and validation of a prediction model for lung cancer metastasis. [PDF]

BMC Pulm Med
Qi W, Li Z, Xu J, Wang T.
europepmc   +1 more source

Alpha-fetoprotein-producing pancreatoblastoma. A case report [PDF]

, 1986
Mikiro Iseki, Toshio Suzuki, Yukihiko Koizumi, Makoto Hirose, William B. Laskin, S Nakazawa, Yoshiharu Ohaki   +6 more
openalex   +1 more source

Mechanistic Insights and Therapeutic Potential of Small Nucleolar RNA Host Genes in the Carcinogenesis of Hepatocellular Carcinoma

Cancer Medicine, Volume 15, Issue 1, January 2026.
ABSTRACT Background Hepatocellular carcinoma (HCC) is one of the major factors endangering human health due to its poor prognosis, resulting from difficulties in early diagnosis and lack of effective treatment measures. Long non‐coding RNAs (lncRNAs), which are RNA molecules that do not translate into proteins, play essential roles in various tumor ...
Jiajia Luo, Zhangxiu Liao, Shuangxia Zhang   +2 more
wiley   +1 more source

Evaluating the GALAD Score for Detection of Hepatocellular Carcinoma in Patients With Cirrhosis. [PDF]

J Clin Gastroenterol
Vo TD, Mai SH, Lam HT.
europepmc   +1 more source

Advantage of Scheduled Upfront Lenvatinib Administration Followed by Transarterial Chemoembolization Therapy Over Lenvatinib Monotherapy in Patients With Unresectable Intermediate‐Stage Hepatocellular Carcinoma: A Multicenter Cohort Study

Cancer Medicine, Volume 15, Issue 1, January 2026.
ABSTRACT Background and Aim Combining systemic chemotherapy with transarterial chemoembolization (TACE) has demonstrated improved outcomes, with promising results for the efficacy of lenvatinib pretreatment combined with TACE in single‐arm studies involving patients with hepatocellular carcinoma (HCC).
Nobuhito Taniki, Keisuke Ojiro, Ryosuke Kasuga, Yukie Nakadai, Takaya Tabuchi, Po‐Sung Chu, Shingo Usui, Hitomi Hoshi, Fumihiko Kaneko, Akihiro Yamaguchi, Jun Koizumi, Hirotoshi Ebinuma, Masashi Tamura, Jitsuro Tsukada, Masanori Inoue, Seishi Nakatsuka, Yasushi Hasegawa, Yuta Abe, Minoru Kitago, Masahiro Jinzaki, Yuko Kitagawa, Takanori Kanai, Nobuhiro Nakamoto   +22 more
wiley   +1 more source

Development and Validation of a Lectin-independent Liquid Chromatography-Tandem Mass Spectrometry Method for Serum Glycosylated Alpha-fetoprotein Analysis and Comparison with a Liquid-phase Binding Assay. [PDF]

Ann Lab Med
Kim H, Park J, Suh H, Lee S, Park Y, Yang WS, Minn D, Kim SS, Cheong JY, Baek JH.   +9 more
europepmc   +1 more source

Gender‐adjusted multiples of the median in amniotic fluid alpha‐fetoprotein‐screening for neural‐tube defects halve false‐positive rate without affecting detection rate [PDF]

, 2001
P. Kozlowski, Alexander Johannes Knippel, R. Stressig   +2 more
openalex   +1 more source

Predictive Value of Serum Autotaxin for Hepatocellular Carcinoma Recurrence After Curative Radiofrequency Ablation

Cancer Medicine, Volume 15, Issue 1, January 2026.
Serum autotaxin (ATX) is a novel and robust biomarker for predicting hepatocellular carcinoma (HCC) recurrence after curative radiofrequency ablation (RFA). Elevated ATX levels independently predict recurrence, outperforming traditional markers and highlighting its potential for personalized post‐RFA surveillance strategies. ABSTRACT Background Despite
Takanobu Iwadare, Hiroyuki Kobayashi, Takefumi Kimura, Taiki Okumura, Taro Nakajima, Shun‐ichi Wakabayashi, Yuki Yamashita, Naoyuki Fujimori, Hideo Kunimoto, Satoshi Shimamoto, Koji Igarashi, Takuro Uchida, Takeji Umemura, Naoki Tanaka   +13 more
wiley   +1 more source

Protein induced by vitamin K absence or antagonist II as a prognostic marker in hepatocellular carcinoma patients with normal serum alpha-fetoprotein levels. [PDF]

J Chin Med Assoc
Huang KJ, Ho CT, Lee PC, Chen SC, Liu CA, Chou SC, Lee IC, Huang YH, Luo JC, Hou MC, Wu JC, Su CW.   +11 more
europepmc   +1 more source